← FDA DRUG APPROVALS

FDA ANDA · ANDA089362

LIDOCAINE HYDROCHLORIDE

Sponsor: ABBOTT

APPLICATION
ANDA089362
TYPE
ANDA
ORIGINAL APPROVAL
1988-05-25
LATEST ACTION
1988-05-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 20% · INJECTABLE · INJECTION

Approval history

1988-05-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →